Precigen Inc (PGEN) concluded trading on Thursday at a closing price of $1.34, with 4.69 million shares of worth about $6.28 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -18.79% during that period and on January 23, 2025 the price saw a gain of about 18.58%. Currently the company’s common shares owned by public are about 292.87M shares, out of which, 163.53M shares are available for trading.
Stock saw a price change of 18.58% in past 5 days and over the past one month there was a price change of 84.62%. Over the period of past 52 weeks, stock dropped to lowest price of $0.65 but also hit the highest price of $1.93 during that period. The average intraday trading volume for Precigen Inc shares is 1.39 million. The stock is currently trading 25.06% above its 20-day simple moving average (SMA20), while that difference is up 44.87% for SMA50 and it goes to 13.47% higher than SMA200.
Precigen Inc (NASDAQ: PGEN) currently have 292.87M outstanding shares and institutions hold larger chunk of about 26.18% of that.
The stock has a current market capitalization of $392.44M and its 3Y-monthly beta is at 1.63. It has posted earnings per share of -$0.55 in the same period. It has Quick Ratio of 1.63 while making debt-to-equity ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PGEN, volatility over the week remained 11.09% while standing at 13.42% over the month.
Analysts are in expectations that Precigen Inc (PGEN) stock would likely to be making an EPS of -0.06 in the current quarter, while forecast for next quarter EPS is -0.05 and it is -0.22 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.07 which is -0.04 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.09 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -18.97% while it is estimated to increase by 55.60% in next year.
On November 18, 2022, Cantor Fitzgerald Initiated their recommendations, while on February 25, 2021, Stifel Initiated their ratings for the stock with a price target of $13. Stock get an Overweight rating from Wells Fargo on February 22, 2021.
